# US Quality Core Medication - US Quality Core Implementation Guide v0.1.0

* [**Table of Contents**](toc.md)
* [**Artifacts Summary**](artifacts.md)
* **US Quality Core Medication**

## Resource Profile: US Quality Core Medication 

| | |
| :--- | :--- |
| *Official URL*:http://fhir.org/guides/astp/us-quality-core/StructureDefinition/us-quality-core-medication | *Version*:0.1.0 |
| Active as of 2026-03-31 | *Computable Name*:USQualityCoreMedication |

 
Profile of Medication for decision support/quality metrics. Defines the core set of elements and extensions for quality rule and measure authors. 

**Usage**
  See the [patterns](patterns.md) page for implementation and usage patterns.  

```
define function "GetMedicationCode"(request MedicationRequest):
  if request.medication is CodeableConcept then
    request.medication as CodeableConcept
  else
    (singleton from ([Medication] M where M.id = GetId((request.medication as Reference).reference))).code

```

### Examples

 

| |
| :--- |
| [Example of an IV medication - Alemtuzumab](Medication-example.md) |

 

**USCDI+ Quality Elements:**

* code: (USCDI+ Quality) (USCDI) Codes that identify this medication

**Usages:**

* Refer to this Profile: [US Quality Core AdverseEvent](StructureDefinition-us-quality-core-adverseevent.md), [US Quality Core Medication](StructureDefinition-us-quality-core-medication.md), [US Quality Core MedicationAdministration](StructureDefinition-us-quality-core-medicationadministration.md), [US Quality Core MedicationDispense](StructureDefinition-us-quality-core-medicationdispense.md) and [US Quality Core MedicationStatement](StructureDefinition-us-quality-core-medicationstatement.md)
* Examples for this Profile: [Medication/example](Medication-example.md)
* CapabilityStatements using this Profile: [US Quality Core Client CapabilityStatement](CapabilityStatement-us-quality-core-client.md) and [US Quality Core Server CapabilityStatement](CapabilityStatement-us-quality-core-server.md)

You can also check for [usages in the FHIR IG Statistics](https://packages2.fhir.org/xig/fhir.astp.us-quality-core|current/StructureDefinition/us-quality-core-medication)

### Formal Views of Profile Content

 [Description of Profiles, Differentials, Snapshots and how the different presentations work](http://build.fhir.org/ig/FHIR/ig-guidance/readingIgs.html#structure-definitions). 

 

Other representations of profile: [CSV](StructureDefinition-us-quality-core-medication.csv), [Excel](StructureDefinition-us-quality-core-medication.xlsx), [Schematron](StructureDefinition-us-quality-core-medication.sch) 



## Resource Content

```json
{
  "resourceType" : "StructureDefinition",
  "id" : "us-quality-core-medication",
  "url" : "http://fhir.org/guides/astp/us-quality-core/StructureDefinition/us-quality-core-medication",
  "version" : "0.1.0",
  "name" : "USQualityCoreMedication",
  "title" : "US Quality Core Medication",
  "status" : "active",
  "experimental" : false,
  "date" : "2026-03-31",
  "publisher" : "ASTP",
  "contact" : [{
    "telecom" : [{
      "system" : "url",
      "value" : "https://www.healthit.gov/"
    }]
  }],
  "description" : "Profile of Medication for decision support/quality metrics. Defines the core set of elements and extensions for quality rule and measure authors.",
  "jurisdiction" : [{
    "coding" : [{
      "system" : "urn:iso:std:iso:3166",
      "code" : "US",
      "display" : "United States of America"
    }],
    "text" : "USA"
  }],
  "fhirVersion" : "4.0.1",
  "mapping" : [{
    "identity" : "script10.6",
    "uri" : "http://ncpdp.org/SCRIPT10_6",
    "name" : "Mapping to NCPDP SCRIPT 10.6"
  },
  {
    "identity" : "rim",
    "uri" : "http://hl7.org/v3",
    "name" : "RIM Mapping"
  },
  {
    "identity" : "w5",
    "uri" : "http://hl7.org/fhir/fivews",
    "name" : "FiveWs Pattern Mapping"
  },
  {
    "identity" : "v2",
    "uri" : "http://hl7.org/v2",
    "name" : "HL7 v2 Mapping"
  }],
  "kind" : "resource",
  "abstract" : false,
  "type" : "Medication",
  "baseDefinition" : "http://hl7.org/fhir/us/core/StructureDefinition/us-core-medication",
  "derivation" : "constraint",
  "differential" : {
    "element" : [{
      "id" : "Medication",
      "path" : "Medication"
    },
    {
      "id" : "Medication.code",
      "extension" : [{
        "url" : "http://hl7.org/fhir/us/core/StructureDefinition/uscdi-requirement",
        "valueBoolean" : true
      },
      {
        "url" : "http://fhir.org/guides/astp/us-quality-core/StructureDefinition/uscdiplusquality",
        "valueBoolean" : true
      }],
      "path" : "Medication.code",
      "short" : "(USCDI+ Quality) (USCDI) Codes that identify this medication"
    },
    {
      "id" : "Medication.manufacturer",
      "path" : "Medication.manufacturer",
      "type" : [{
        "code" : "Reference",
        "targetProfile" : ["http://fhir.org/guides/astp/us-quality-core/StructureDefinition/us-quality-core-organization"]
      }],
      "mustSupport" : false
    },
    {
      "id" : "Medication.ingredient.item[x]",
      "path" : "Medication.ingredient.item[x]",
      "type" : [{
        "code" : "CodeableConcept"
      },
      {
        "code" : "Reference",
        "targetProfile" : ["http://fhir.org/guides/astp/us-quality-core/StructureDefinition/us-quality-core-substance",
        "http://fhir.org/guides/astp/us-quality-core/StructureDefinition/us-quality-core-medication"]
      }],
      "mustSupport" : false
    },
    {
      "id" : "Medication.ingredient.isActive",
      "path" : "Medication.ingredient.isActive",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "boolean"
      }],
      "mustSupport" : false,
      "mapping" : [{
        "identity" : "qidam",
        "map" : "Not in QIDAM, but added because it was determined to be important for drug-allergy checking. For example, if the patient is allergic to Depakote\n(a trade name, and includes blue dye as an inactive ingredient), then when patient is prescribed warfarin, it shoots out a drug-allergy alert because warfarin also contains blue dye.  Providers hate this. We recently overcame this problem by having the drug-allergy alert interaction settings only check for allergies to active ingredients."
      }]
    }]
  }
}

```
